Earnings Feed
Start Free
Home/Filings/4/0001140361-13-010689
4//SEC Filing

Soni Rakesh 4

Accession 0001140361-13-010689

CIK 0001228627other
View on SEC.govCompany Profile

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 4:23 PM ET

Size

8.9 KB

Accession

0001140361-13-010689

Insider Transaction Report

Form 4
Period: 2013-03-01
REXAHN PHARMACEUTICALS, INC.RNN
Soni Rakesh
Chief Business Officer
Transactions
  • Award

    Stock Option (right to purchase)

    2013-03-01+50,000→ 50,000 total
    Exercise: $0.31Exp: 2023-03-01→ Common Stock (50,000 underlying)
Holdings

  • Stock Option (right to purchase)

    Exercise: $0.78Exp: 2018-12-11→ Common Stock (250,000 underlying)
    250,000

  • Common Stock

    2,700

  • Stock Option (right to purchase)

    Exercise: $1.29Exp: 2018-09-30→ Common Stock (300,000 underlying)
    300,000
Footnotes (3)
  • [F1]Options will vest and be exercisable based on the following schedule: 15,000 on March 1, 2014, 15,000 on March 1, 2015, and 20,000 on March 1, 2016
  • [F2]Options vested and became exercisable based on the following schedule 75,000 on December 11, 2009, 75,000 on December 11, 2010, and 100,000 on December 11, 2011.
  • [F3]Options vested and became exercisable based on the following schedule 90,000 on September 30, 2009, 90,000 on September 30, 2010, and 120,000 on September 30, 2011.

Documents

1 file

Issuer

REXAHN PHARMACEUTICALS, INC.

CIK 0001228627

→
Entity typeother

Related Parties

1
  • filerCIK 0001440181

Filing Metadata

Form type
4
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 4:23 PM ET
Size
8.9 KB
View on SEC.gov